Search

01/03/2026 Avelumab (Ave) in combination with other anticancer agents as first-line maintenance (1LM) treatment for advanced urothelial carcinoma (aUC): Primary analysis from the JAVELIN Bladder Medley phase 2 trial.
Hoffman-Censits, J, Tsiatas, M, Chang, PMH, Kim, M, Zagouri, F, Shin, SJ, Kim, SH, Su, HYL, Arija, JAA, Maroto-Rey, JP, Antonuzzo, L, Maruzzo, M, Tambaro, R, Blais, N, Rottey, S, Gakis, G, Schneider, A, Tyroller, K, Jacob, N, Valderrama, BP. Avelumab (Ave) in combination with other anticancer agents as first-line maintenance (1LM) treatment for advanced urothelial carcinoma (aUC): Primary analysis from the JAVELIN Bladder Medley phase 2 trial.. JOURNAL OF CLINICAL ONCOLOGY. 2026; 44(7_SUPPL)DOI:10.1200/JCO.2026.44.7_suppl.739. PMID:. IF:41.900(Q1/1D).
01/04/2026 Fulzerasib plus cetuximab in first-line KRASG12C-mutated nonsmall-cell lung cancer (KROCUS): a single-arm, multicentre, phase 1b/2 trial
Gregorc, V, Majem, M, Lo Russo, G, Maio, M, Salvagni, S, Gutiérrez-Calderon, V, Gonzalez-Cao, M, Contreras, SS, Koumarianou, A, Bearz, A, Bernabé-Caro, R, Viteri, S, de Sanmamed, MF, Zagouri, F, Bueno, TM, Lazzari, C, Martínez-Recio, S, Giménez-Capitán, A, Zhang, Y, Shan, Y, Zhu, HQ, Zhao, CQ, Shen, HG, Wang, Y, Rosell, R. Fulzerasib plus cetuximab in first-line KRASG12C-mutated nonsmall-cell lung cancer (KROCUS): a single-arm, multicentre, phase 1b/2 trial. LANCET ONCOLOGY. 2026; 27(4)DOI:10.1016/S1470-2045(25)00764-8. PMID:41926959. IF:35.900(Q1/1D).
26/03/2026 Evaluating the added value of a multifactorial model over gene-based risk estimates in breast cancer prediction for healthy carriers of pathogenic variants
Garcia, AM, Rezqallah-Arón, A, Duran-Lozano, L, López-Fernández, A, Darder, E, Alfonso, R, Cartró, M, Cruellas, M, Reig-Jané, J, Roqué, A, Tuset, N, Cajal, TRY, Brunet, J, Balmaña, J. Evaluating the added value of a multifactorial model over gene-based risk estimates in breast cancer prediction for healthy carriers of pathogenic variants. EUROPEAN JOURNAL OF CANCER. 2026; 237DOI:10.1016/j.ejca.2026.116560. PMID:. IF:7.100(Q1/2D).
01/03/2026 Real-world data of enfortumab vedotin in patients with advanced urothelial cancer in Spain: The ENFANTS-GUARD study.
Villarrubia, JE, Fita, MJJ, de Liaño, AG, Cerrillomd, JM, Cruz, P, Anguera, G, Puente, J, Torras, OR, Navarro-Gorro, N, Pinto, A, Ruiz, SG, Cacho, D, Maeso, IG, González, NS, Lainez, N, Herranz, UA, Carrera-Lasfuentes, P, Climent, MA, Macías, NR, Castellano, D. Real-world data of enfortumab vedotin in patients with advanced urothelial cancer in Spain: The ENFANTS-GUARD study.. JOURNAL OF CLINICAL ONCOLOGY. 2026; 44(7_SUPPL)DOI:10.1200/JCO.2026.44.7_suppl.700. PMID:. IF:41.900(Q1/1D).
12/03/2026 IMMUNOSARC II Master Trial: Phase II Study of Sunitinib and Nivolumab in Clear Cell Sarcoma Cohort
Martin-Broto, J, Strauss, SJ, Palmerini, E, Valverde, C, Sebio, A, Redondo, A, Stacchiotti, S, Grignani, G, Aliberti, S, Diaz-Beveridge, R, Billalabeitia, EG, Cruz, J, Carrasco-Garcia, I, Ibrahim, T, Diaz-Martin, J, Salguero-Aranda, C, Gutierrez, A, Mayordomo-Aranda, E, Ramos, R, Merino, J, Collini, P, Tirabosco, R, Bague, S, Romagosa, C, Carrera, MA, Ledesma, P, Hindi, N, Moura, DS. IMMUNOSARC II Master Trial: Phase II Study of Sunitinib and Nivolumab in Clear Cell Sarcoma Cohort. Cancer Communications. 2026; 46DOI:10.34133/cancomm.0015. PMID:41836677. IF:24.900(Q1/1D).
01/04/2026 Identification of prognostic variables in patients with recurrent head and neck squamous cell carcinoma treated with salvage surgery: Implications for treatment with immunotherapy
Holgado, A, Llansana, A, Vázquez, C, Gallego, O, Aguado, M, Valero, C, León, X. Identification of prognostic variables in patients with recurrent head and neck squamous cell carcinoma treated with salvage surgery: Implications for treatment with immunotherapy. ORAL ONCOLOGY. 2026; 175DOI:10.1016/j.oraloncology.2026.107903. PMID:41722172. IF:3.900(Q1/2D).
01/03/2026 SEOM-AEEMT consensus on occupational cancer and cancer-associated disability
Mezquita, L, Vicente-Herrero, MT, Cruz, P, de la Torre, MVRI, Hidalgo-Coloma, J, Garcia, LC, Gallego, O, Calvo, A, Martinez, K, Perez-Altozano, J, Molina, R, Garcia-Pardo, M, Gutierrez-Sainz, L, Moreno-Atahonero, E, Ore-Arce, M, Serrano, C, Terradillos-Garcia, MJ, Valero, MR, Reinoso-Barbero, L, Rodriguez, CA, Calvo-Cerrada, B. SEOM-AEEMT consensus on occupational cancer and cancer-associated disability. Clinical & Translational Oncology. 2026; 28(3)DOI:10.1007/s12094-025-04037-2. PMID:40956506. IF:2.500(Q3/6D).
09/03/2026 Multidisciplinary Treatment of Inguinoscrotal Sarcomas: Analysis of 39 Cases Treated by Surgical Approach
Samsó, RH, Cabré, LC, Abós, SG, Solerdelcoll, MS, Majercakova, K, García, AS, Alegria, IG, Garrido, MF, Duarte, AM, López, JAG. Multidisciplinary Treatment of Inguinoscrotal Sarcomas: Analysis of 39 Cases Treated by Surgical Approach. Cancers. 2026; 18(5)DOI:10.3390/cancers18050876. PMID:41827809. IF:4.400(Q2/3D).
16/03/2026 TFE3-Rearranged and TFEB-Altered Renal Cell Carcinomas: Molecular Landscape and Therapeutic Advances
Portu, M, Balsa, M, Cotaina, M, Anguera, G, del Muro, XG, Algaba, F, Maroto, P. TFE3-Rearranged and TFEB-Altered Renal Cell Carcinomas: Molecular Landscape and Therapeutic Advances. Cancers. 2026; 18(6)DOI:10.3390/cancers18060958. PMID:41899560. IF:4.400(Q2/3D).
01/01/2025 Precision targeting of CXCR4+leukemia cells by a humanized MMAE-nanoconjugate in an AML mouse model.
Garcia-Leon, Annabel, Mendoza, Julian I, Rueda, Ariana, Alba-Castellon, Lorena, Nomdedeu, Josep F, Gallardo, Alberto, Sierra, Jorge, Garrido, Ana, Vazquez, Esther, Villaverde, Antonio, Mangues, Ramon, Unzueta, Ugutz, Casanova, Isolda. Precision targeting of CXCR4+leukemia cells by a humanized MMAE-nanoconjugate in an AML mouse model.. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2025; 192DOI:10.1016/j.biopha.2025.118573. PMID:. IF:(Q/D).
01/09/2024 Paradoxical cell targeting of calreticulin-empowered, protein-only nanoparticles
Parladé, E, García-Leon, A, Voltà-Durán, E, Unzueta, U, Mangues, R, Casanova, I, Villaverde, A, Váquez, E. Paradoxical cell targeting of calreticulin-empowered, protein-only nanoparticles. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS. 2024; 202DOI:10.1016/j.ejpb.2024.114410. PMID:39004320. IF:4.300(Q1/2D).
01/12/2022 Low-risk polycythemia vera treated with phlebotomies: clinical characteristics, hematologic control and complications in 453 patients from the Spanish Registry of Polycythemia Vera (vol 101, 2231, 2022)
Triguero, A, Pedraza, A, Perez-Encinas, M, Mata-Vazquez, MI, Velez, P, Fox, L, Gomez-Calafat, M, Garcia-Delgado, R, Gasior, M, Ferrer-Marin, F, Garcia-Gutierrez, V, Angona, A, Gomez-Casares, MT, Cuevas, B, Martinez, C, Perez, R, Raya, JM, Guerrero, L, Murillo, I, Bellosillo, B, Hernandez-Boluda, JC, Sanz, C, Alvarez-Larran, A. Low-risk polycythemia vera treated with phlebotomies: clinical characteristics, hematologic control and complications in 453 patients from the Spanish Registry of Polycythemia Vera (vol 101, 2231, 2022). ANNALS OF HEMATOLOGY. 2022; 101(12)DOI:10.1007/s00277-022-05005-4. PMID:36264368. IF:3.500(Q2/5D).
01/01/2026 Allogeneic Hematopoietic Stem Cell Transplantation in Elderly Patients: The Experience of the Grupo Espanol de Trasplante Hematopoyetico y Terapia Celular
Fernández-Luis, S, Bermúdez, A, San Segundo, LY, González, MB, Asensio, SM, Esquirol, A, García-Cadenas, I, Pascual, MJ, Herruzo, B, Salas, MQ, Alburquerque-Prieto, C, Viguria-Alegría, MC, Pérez, A, Hernani, R, Mas, MH, Villalba, M, Calvo, CM, Fabbri, N, González-Rodriguez, AP, Bailén, R, Tomás, LG, Maño, LG, Salinas, AS, Calbacho, M, Bento, L, Balari, AS. Allogeneic Hematopoietic Stem Cell Transplantation in Elderly Patients: The Experience of the Grupo Espanol de Trasplante Hematopoyetico y Terapia Celular. TRANSPLANTATION. 2026; 110(1)DOI:10.1097/TP.0000000000005446. PMID:40524321. IF:5.000(Q1/1D).
01/12/2024 Real-World Evidence on Adverse Events and Healthcare Resource Utilization in Patients with Chronic Lymphocytic Leukaemia in Spain Using Natural Language Processing: The SRealCLL Study
Abrisqueta-Costa, P, García-Marco, JA, Gutiérrez, A, Hernández-Rivas, JA, Andreu-Lapiedra, R, Arguello-Tomas, M, Leiva-Farré, C, López-Roda, MD, Callejo-Mellén, A, Alvarez-García, E, Loscertales, J. Real-World Evidence on Adverse Events and Healthcare Resource Utilization in Patients with Chronic Lymphocytic Leukaemia in Spain Using Natural Language Processing: The SRealCLL Study. Cancers. 2024; 16(23)DOI:10.3390/cancers16234004. PMID:39682190. IF:4.400(Q2/3D).
01/01/2026 Outcomes of primary graft failure in acute myeloid leukemia patients following unrelated transplantation with post-transplant cyclophosphamide: a study from the ALWP/EBMT
Nagler, A, Galimard, JE, Kayser, S, Kulagin, A, Blaise, D, Parovichnikova, E, Versluis, J, Itäla-Remes, M, Choi, G, Bufarull, RM, Sica, S, Roeven, MWH, von dem Borne, P, Bazarbachi, A, Sanz, J, Mohty, M, Ciceri, F. Outcomes of primary graft failure in acute myeloid leukemia patients following unrelated transplantation with post-transplant cyclophosphamide: a study from the ALWP/EBMT. BONE MARROW TRANSPLANTATION. 2026; 61(1)DOI:10.1038/s41409-025-02726-8. PMID:41109900. IF:5.200(Q1/1D).
07/02/2024 Denervation-activated STAT3-IL-6 signalling in fibro-adipogenic progenitors promotes myofibres atrophy and fibrosis (vol 20, pg 917, 2018)
Madaro, L, Passafaro, M, Sala, D, Etxaniz, U, Lugarini, F, Proietti, D, Alfonsi, MV, Nicoletti, C, Gatto, S, De Bardi, M, Rojas-Garcia, R, Giordani, L, Marinelli, S, Pagliarini, V, Sette, C, Sacco, A, Puri, PL. Denervation-activated STAT3-IL-6 signalling in fibro-adipogenic progenitors promotes myofibres atrophy and fibrosis (vol 20, pg 917, 2018). NATURE CELL BIOLOGY. 2024; 26(3)DOI:10.1038/s41556-024-01365-3. PMID:38326555. IF:19.100(Q1/1D).
09/07/2024 Single cell RNA sequencing of human FAPs reveals different functional stages in Duchenne muscular dystrophy
Fernández-Simón, E, Piñol-Jurado, P, Gokul-Nath, R, Unsworth, A, Alonso-Pérez, J, Schiava, M, Nascimento, A, Tasca, G, Queen, R, Cox, D, Suarez-Calvet, X, Díaz-Manera, J. Single cell RNA sequencing of human FAPs reveals different functional stages in Duchenne muscular dystrophy. Frontiers in Cell and Developmental Biology. 2024; 12DOI:10.3389/fcell.2024.1399319. PMID:39045456. IF:4.300(Q1/1D).
01/04/2026 Pathogenic or Likely Pathogenic GRN Variants Are Found in 0.1% of Parkinson's Disease Patients
Ganoza, CA, Westenberger, A, Paul, JJ, Curado, F, Rennecke, J, Mannepalli, S, Zonic, E, Saravanakumar, D, Paknia, O, Al-Ali, R, Laabs, B, Csoti, I, Valzania, F, Vandenberghe, W, Reetz, K, Afshari, M, Hassin-Baer, S, Fonoff, ET, Gruber, D, de Rosa, A, Musacchio, T, Aguiar, PD, Negrotti, A, Tumas, V, Gomez-Esteban, JC, Gurevich, T, Pavese, N, Kulisevsky, J, Sammler, E, Klein, C, Bauer, P, Beetz, C. Pathogenic or Likely Pathogenic GRN Variants Are Found in 0.1% of Parkinson's Disease Patients. MOVEMENT DISORDERS. 2026; 41(4)DOI:10.1002/mds.70161. PMID:41439479. IF:7.600(Q1/1D).
01/06/2026 Advancing the Treatment of Motor Fluctuations in Parkinson's Disease with a Next-Generation Levodopa/Carbidopa Formulation
Stocchi, F, Knecht, M, Marjanovic, I, Wach, A, Kopra, J, Kulisevsky, J. Advancing the Treatment of Motor Fluctuations in Parkinson's Disease with a Next-Generation Levodopa/Carbidopa Formulation. Neurology and Therapy. 2026; 15(3)DOI:10.1007/s40120-026-00898-z. PMID:41724884. IF:4.800(Q1/2D).
31/01/2026 Ten-year population-based assessment of multimorbidity burden progression in a regional cohort of 5.5 million adults
Valero-Bover, D, Monterde, D, Carot-Sans, G, Vela, E, González-Colom, R, Roca, J, Pontes, C, Michelena, X, Nogueras, MM, Aparicio, P, Corrales, I, Biec, T, Cano, I, Piera-Jiménez, J. Ten-year population-based assessment of multimorbidity burden progression in a regional cohort of 5.5 million adults. npj Digital Medicine. 2026; 9(1)DOI:10.1038/s41746-026-02395-x. PMID:41620560. IF:15.100(Q1/1D).
07/05/2026 The role of Spanish clinical pharmacologists in economic evaluations of health technologies
Delgado-Espinoza, CE, Antonijoan, RM, Martínez-Zapata, MJ. The role of Spanish clinical pharmacologists in economic evaluations of health technologies. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2026; 82(6)DOI:10.1007/s00228-026-04070-2. PMID:42091708. IF:2.700(Q2/5D).
14/03/2024 Prevalence of use of on-label and off-label psychotropics in the Greek pediatric population
Pesiou, S, Barcelo, R, Papazisis, G, Torres, F, Pontes, C. Prevalence of use of on-label and off-label psychotropics in the Greek pediatric population. Frontiers in Pharmacology. 2024; 15DOI:10.3389/fphar.2024.1348887. PMID:38549664. IF:4.800(Q1/2D).
01/05/2026 Low-intervention clinical trials in Spain: Do they progress?
Delgado-Espinoza, CE, Pestana, MJC, Amaro, K, Antonijoan, RM, Pontes, C. Low-intervention clinical trials in Spain: Do they progress?. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 2026; 92(5)DOI:10.1002/bcp.70409. PMID:41406957. IF:3.000(Q2/4D).
01/01/2025 Comment on the article 'Misinformation about interchangeable biosimilars'
Cohen, HP, Pontes, C, de Mora, F. Comment on the article 'Misinformation about interchangeable biosimilars'. Gabi Journal-Generics And Biosimilars Initiative Journal. 2025; 14(1)DOI:10.5639/gabij.2025.1401.003. PMID:. IF:(Q/D).
01/02/2024 Electroconvulsive therapy-induced volumetric brain changes converge on a common causal circuit in depression
Argyelan, M, Deng, ZD, Ousdal, OT, Oltedal, L, Angulo, B, Baradits, M, Spitzberg, AJ, Kessler, U, Sartorius, A, Dols, A, Narr, KL, Espinoza, R, van Waarde, JA, Tendolkar, I, van Eijndhoven, P, van Wingen, GA, Takamiya, A, Kishimoto, T, Jorgensen, MB, Jorgensen, A, Paulson, OB, Yrondi, A, Péran, P, Soriano-Mas, C, Cardoner, N, Cano, M, van Diermen, L, Schrijvers, D, Belge, JB, Emsell, L, Bouckaert, F, Vandenbulcke, M, Kiebs, M, Hurlemann, R, Mulders, PCR, Redlich, R, Dannlowski, U, Erhan, K, Kritzer, MD, Ellard, KK, Camprodon, JA, Petrides, G, Malhotra, AK, Abbott, CC. Electroconvulsive therapy-induced volumetric brain changes converge on a common causal circuit in depression. MOLECULAR PSYCHIATRY. 2024; 29(2)DOI:10.1038/s41380-023-02318-2. PMID:37985787. IF:10.100(Q1/1D).
Cognitive discrepancy patterns and their association with psychosocial functioning across affective disorders.
Vicent-Gil M, Serra-Blasco M, Trujols J, Navarra-Ventura G, de Diego-Adeliño J, Puigdemont D, Alemany C, Pérez J, Portella MJ, Cardoner N. Cognitive discrepancy patterns and their association with psychosocial functioning across affective disorders.. Spanish Journal Of Psychiatry And Mental Health. ; DOI:10.1016/j.sjpmh.2025.05.001. PMID:40886773. IF:(Q/D).
01/10/2024 Context matters: the evolving use of biomarkers in Alzheimer's disease care
Fortea, J. Context matters: the evolving use of biomarkers in Alzheimer's disease care. EBioMedicine. 2024; 108DOI:10.1016/j.ebiom.2024.105387. PMID:39366842. IF:10.800(Q1/1D).
24/04/2024 Clinical value of plasma ALZpath pTau217 immunoassay for assessing mild cognitive impairment
Lehmann, S, Schraen-Maschke, S, Vidal, JS, Delaby, C, Buee, L, Blanc, F, Paquet, C, Allinquant, B, Bombois, S, Gabelle, A, Hanon, O. Clinical value of plasma ALZpath pTau217 immunoassay for assessing mild cognitive impairment. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 2024; 95(11)DOI:10.1136/jnnp-2024-333467. PMID:38658136. IF:7.500(Q1/1D).
01/02/2022 Detection of azole resistance in Aspergillus fumigatus complex isolates MALDI-TOF mass
Zvezdanova, ME, Arroyo, MJ, Mendez, G, Candela, A, Mancera, L, Rodriguez, JG, Serra, JL, Jimenez, R, Lozano, I, Castro, C, Lopez, C, Munoz, P, Guinea, J, Escribano, P, Rodriguez-Sanchez, B, Sánchez-Reus F.. Detection of azole resistance in Aspergillus fumigatus complex isolates MALDI-TOF mass. CLINICAL MICROBIOLOGY AND INFECTION. 2022; 28(2)DOI:10.1016/j.cmi.2021.06.005. PMID:34147673. IF:14.200(Q1/1D).
01/06/2026 Next generation sequencing approaches for the detection and characterization of enteroviruses in clinical, public health, and research settings: Expert view of the European non-polio enterovirus network (ENPEN)
Benschop, KSM, Zwagemaker, F, Andersson-Li, L, Andrés, C, Antón, A, Berengua, C, Berginc, N, Bessaud, M, Bisseux, M, Bujaki, E, Canning, B, Christiansen, CB, Couderé, K, Broberg, EK, Cassidy, H, Castilletti, C, Celma, C, Cinek, O, Deézsi-Magyar, N, Eis-Hübinger, AM, Flipse, J, Jirincová, H, Gatej, R, Georgieva, I, Giardina, F, González-Sánchez, A, Hack, B, Helfferich, J, Hutchings, S, Hietanen, E, Hönemann, M, Virant, MJ, Kalogera, E, Johannesen, CK, Kenicer, J, Kleines, M, Lagarejos, E, Landaas, ET, Kandulu, CC, Labrador, FXL, Lunar, MM, Maier, M, Majumdar, M, Martin, J, McClure, CP, Muñoz-Almagro, C, Osep, A, Overbo, J, Palminha, P, Papa, A, Pariani, E, Pellegrinelli, L, Pietsch, C, Piralla, A, Poljak, M, Pomari, E, Prats-Méndez, I, Rector, A, Reuter, G, Riess, M, Ruta, S, Schibler, M, Nilsen, HJS, Simmonds, P, Sourvinos, G, Szomor, K, Susi, P, Tabain, I, Vallely, P, von Eije, KJ, Weil, M, Wieczorek, M, Wollants, E, Wolthers, KC, Zuckerman, NS, Fischer, TK, Harvala, H. Next generation sequencing approaches for the detection and characterization of enteroviruses in clinical, public health, and research settings: Expert view of the European non-polio enterovirus network (ENPEN). JOURNAL OF CLINICAL VIROLOGY. 2026; 184DOI:10.1016/j.jcv.2026.105940. PMID:41905022. IF:3.400(Q2/5D).
07/03/2026 Clinical Outcomes and Quality of Life in Older De Novo Kidney Transplant Recipients Under Once-Daily Tacrolimus Formulations: The BITACORA Study
Andrés, A, Jiménez, S, Regidor, MJA, Moreso, F, Crespo, M, Cabañas, NS, Gómez, G, López, V, Corte, MDCD, Fraile-Gómez, P, Lorenzo, I, San Millán, JCR, Cañas, L, Benot, AR, Romero, NC, Diekmann, F, Mendiluce, A, Rivera, CF, Gallego, R, Jiménez, C, Martin-Moreno, PL, Tagarro, EF, Díaz, C, Urcuyo, BM, Roncero, FMG. Clinical Outcomes and Quality of Life in Older De Novo Kidney Transplant Recipients Under Once-Daily Tacrolimus Formulations: The BITACORA Study. CLINICAL TRANSPLANTATION. 2026; 40(3)DOI:10.1111/ctr.70501. PMID:41793258. IF:1.900(Q2/4D).
01/05/2026 Managing Enterococcus faecium bloodstream infection: a Delphi document on clinical recommendations and research agenda
Rinaldi, M, Bartoletti, M, Cojutti, P, Escolà-Vergé, L, Fernández-Hidalgo, N, Hornuss, D, Gatti, M, Gudiol, C, Gutiérrez-Gutiérrez, B, López-Cortés, LE, Kern, WV, Los-Arcos, I, Muñoz, P, Oliva, A, Papadimitriou-Olivgeris, M, Pai, M, Pea, F, Pericas, JM, Rieg, S, Russo, A, Soriano, A, Thursky, K, Udy, A, Venditti, M, Yahav, D, Mo, Y, Viale, P, Giannella, M. Managing Enterococcus faecium bloodstream infection: a Delphi document on clinical recommendations and research agenda. Eclinicalmedicine. 2026; 95DOI:10.1016/j.eclinm.2026.103925. PMID:42088065. IF:10.000(Q1/1D).
01/04/2026 Geographical Differences in the Epidemiology and Treatment of Candida Prosthetic Joint Infections
Mamona-Kilu, C, Lora-Tamayo, J, McNally, M, Duran, C, Ho, RSMY, Scarborough, M, Dudareva, M, Bonnet, E, Escolà-Vergé, L, Pardo, DR, Jesuthasan, G, Senneville, E, Thill, P, Klein, S, Ronde-Oustau, C, Redó, MLS, Corvec, S, Rossi, N, Esteban, J, Lemaignen, A, Ribeiro, TC, Mazet, J, Sasso, M, Salles, MJC, Mancheño-Losa, M, Giordano, G, Frank, BJH, Hofstaetter, JG, Allende, JMB, Lortholary, O, Fourcade, C, Morata, L, Soriano, A, Dinh, A. Geographical Differences in the Epidemiology and Treatment of Candida Prosthetic Joint Infections. Open Forum Infectious Diseases. 2026; 13(4)DOI:10.1093/ofid/ofag208. PMID:41988413. IF:3.800(Q1/3D).
04/04/2026 Epidemiological and Clinical Characteristics of the Enterovirus D68 Outbreak in Spain in 2024
Camacho, J, García-Ibáñez, N, Fernández-García, MD, Biya, Y, de Pedro, ER, Gutiérrez, A, Nieto, MC, Ruiz-García, MM, Pastor-Fajardo, MT, Lagarejos, E, Simón, CD, Navascués, A, Moreno-Docón, A, Gozalo-Marguello, M, Berengua, C, Antequera, P, Huéscar-Pascual, MD, Calvo, C, Cabrerizo, M. Epidemiological and Clinical Characteristics of the Enterovirus D68 Outbreak in Spain in 2024. JOURNAL OF MEDICAL VIROLOGY. 2026; 98(4)DOI:10.1002/jmv.70887. PMID:41934271. IF:4.600(Q1/1D).
31/03/2026 Experience with Low-Risk Immunologic Delisting Protocols in Highly Sensitized Candidates for Renal Transplantation
Rodriguez-Martin, D, Luchoro-Cerda, JF, Torres-Canizales, JM, Arana-Aliaga, C, Dolores, RPM, Serra-Cabañas, N, Molina-Gomez, M, Melilli, E, Meneghini, MAE, Palou, E, Caro-Oleas, JL. Experience with Low-Risk Immunologic Delisting Protocols in Highly Sensitized Candidates for Renal Transplantation. HLA. 2026; 107DOI:. PMID:. IF:4.100(Q1/1D).
01/05/2026 Impact of COVID-19 on tuberculosis diagnosis in a low-incidence southern European city
Pomar, V, Garrigó, M, Colomé, M, López-Egea, JA, Garcia, E, González, Y, Cermeño, S, Navarro, F, López-Contreras, J. Impact of COVID-19 on tuberculosis diagnosis in a low-incidence southern European city. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2026; 44(5)DOI:10.1016/j.eimc.2026.503173. PMID:. IF:2.500(Q2/5D).
01/09/2024 Overview of Thigh and Leg Anatomical and Sonographic Landmarks in Rheumatic Patients
Balius, R, Pedret, C, Estrada-Alarcón, P, Corominas, H. Overview of Thigh and Leg Anatomical and Sonographic Landmarks in Rheumatic Patients. European Journal Of Rheumatology. 2024; 11DOI:10.5152/eurjrheum.2022.21131. PMID:36052637. IF:(Q/D).
16/08/2024 Utility of applying a diagnostic algorithm in giant cell arteritis based on the level of clinical suspicion
Estrada, P, Moya, P, Narváez, J, Moragues, C, Navarro, V, Camacho, O, Roig, D, Cerdà, D, Heredia, S, Reina, D, Corominas, H. Utility of applying a diagnostic algorithm in giant cell arteritis based on the level of clinical suspicion. MEDICINA CLINICA. 2024; 163(3)DOI:10.1016/j.medcli.2023.11.021. PMID:38278759. IF:2.100(Q2/3D).
01/02/2023 Proteomic profiling for prediction of recurrent cardiovascular event in patients with acute coronary syndrome and obstructive sleep apnea: A post-hoc analysis from the ISAACC study
Zapater, A, Gracia-Lavedan, E, Torres, G, Minguez, O, Pascual, L, Cortijo, A, Martinez, D, Benitez, ID, De Batlle, J, Henriquez-Beltran, M, Abad, J, Duran-Cantolla, J, Urrutia, A, Mediano, O, Masdeu, MJ, Ordax-Carbajo, E, Masa, JF, De la Pena, M, Mayos, M, Coloma, R, Montserrat, JM, Chiner, E, Barbe, F, Sanchez-de-la-Torre, M. Proteomic profiling for prediction of recurrent cardiovascular event in patients with acute coronary syndrome and obstructive sleep apnea: A post-hoc analysis from the ISAACC study. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2023; 158DOI:10.1016/j.biopha.2022.114125. PMID:36549084. IF:6.900(Q1/1D).
01/05/2026 Effectiveness of automatically-adjusted vs manually-adjusted noninvasive ventilation in obesity hypoventilation syndrome: a randomized clinical trial
Sánchez-Quiroga, MA, Benítez, I, Mokhlesi, B, de Terreros, FJG, Roncero, A, Ruiz-Martínez, C, Bretón, M, Troncoso, MF, Herrero, J, López-Martín, S, López-Padilla, D, González, M, de Teran, TD, Caballero-Eraso, C, Martí, S, Peñacoba, P, Galdeano, M, Muñoz-Méndez, J, Barca, J, Barbe, F, Utrabo, I, Duran, JA, Masa, JF, Chiner, E, De-Dios, C, Lázaro, J, Torres, M, Rodríguez-Rodríguez, P, Esteban, C, Núñez, L, Teran, JR, Asensio-Cruz, MI, Sampol, J, Pallero, M, Hernandez-Voth, A, Díaz-Cambriles, T, Arias, E, Sayas, J. Effectiveness of automatically-adjusted vs manually-adjusted noninvasive ventilation in obesity hypoventilation syndrome: a randomized clinical trial. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 2026; 212(5)DOI:10.1093/ajrccm/aamag018. PMID:41738216. IF:19.400(Q1/1D).